home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Overview of Drug Development

 
  March 16, 2011  
     
 
Hyatt Regency Boston, Boston, MA USA
Aug 19 2011 8:30AM - 4:30PM


Provides an introduction to the drug development process under FDA and ICH Guidelines, including how various parts of companies fit into the overall process of pharmaceutical development.

 

WHAT YOU WILL LEARN
·         How the pharmaceutical industry identifies new products and brings them to market
·         Contributions of key groups within the company and how they interact
·         FDA and regulation of the industry
·         Basics of filing a New Drug Application (NDA)
·         Ethical considerations in conducting clinical research
·         Institutional review, informed consent, and financial disclosure
·         Concepts and functions associated with ensuring overall study quality

Event Code:
11421
 
 
Organized by: DIA
Invited Speakers: See website for speaker information
 
Deadline for Abstracts: Call contact
 
Registration:
For detailed program information including faculty and topics, please contact: 

Colleen Buckley

Tel. 215-442-6108

E-mail: colleen.buckley@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.